English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biogen
Bree Gonzales
| Jun 9, 2021
Biogen gets FDA approval for Alzheimer's treatment: 'the first therapy to target the underlying disease process'
Carrie Bradon
| Nov 30, 2017
Biogen names new chief financial officer
Carrie Bradon
| Nov 27, 2017
Biogen to present at conference this month
Nicholas Gueguen
| Jun 11, 2017
European Commission OKs Spinraza to fight spinal muscular atrophy
Jeff Gantt
| Dec 14, 2016
Biogen presents PRIME study data at clinical trials meeting
Amanda Rupp
| Sep 16, 2016
New data for Zinbryta support long-term safety profile
Amanda Rupp
| Aug 12, 2016
Biogen launches new company dedicated to hemophilia
Amanda Rupp
| Jun 23, 2016
McKenzie named new Biogen executive vice president
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
